Lexicon Pharmaceuticals Inc (LXRX)
1.62
-0.09
(-5.26%)
USD |
NASDAQ |
Apr 23, 16:00
1.62
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Price: 1.62 for April 23, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 23, 2024 | 1.71 | 1.78 | 1.59 | 1.62 | 3.436M |
Apr 22, 2024 | 1.68 | 1.858 | 1.67 | 1.71 | 4.093M |
Apr 19, 2024 | 1.63 | 1.69 | 1.60 | 1.65 | 2.991M |
Apr 18, 2024 | 1.67 | 1.73 | 1.62 | 1.63 | 3.715M |
Apr 17, 2024 | 1.72 | 1.78 | 1.61 | 1.62 | 5.562M |
Apr 16, 2024 | 1.83 | 1.84 | 1.69 | 1.695 | 4.592M |
Apr 15, 2024 | 1.95 | 1.96 | 1.84 | 1.87 | 3.492M |
Apr 12, 2024 | 2.01 | 2.039 | 1.93 | 1.97 | 1.870M |
Apr 11, 2024 | 2.03 | 2.09 | 1.975 | 2.03 | 1.750M |
Apr 10, 2024 | 2.04 | 2.04 | 1.97 | 2.02 | 2.599M |
Apr 09, 2024 | 2.11 | 2.168 | 2.035 | 2.07 | 2.217M |
Apr 08, 2024 | 2.07 | 2.11 | 2.03 | 2.09 | 1.333M |
Apr 05, 2024 | 2.04 | 2.095 | 2.01 | 2.06 | 1.234M |
Apr 04, 2024 | 2.08 | 2.19 | 2.03 | 2.06 | 2.014M |
Apr 03, 2024 | 2.22 | 2.239 | 2.03 | 2.04 | 4.392M |
Apr 02, 2024 | 2.27 | 2.28 | 2.18 | 2.21 | 2.046M |
Apr 01, 2024 | 2.45 | 2.45 | 2.28 | 2.28 | 1.805M |
Mar 28, 2024 | 2.18 | 2.47 | 2.13 | 2.40 | 7.061M |
Mar 27, 2024 | 2.00 | 2.29 | 1.992 | 2.19 | 5.171M |
Mar 26, 2024 | 2.10 | 2.17 | 1.96 | 1.98 | 4.400M |
Mar 25, 2024 | 2.26 | 2.355 | 2.12 | 2.12 | 4.182M |
Mar 22, 2024 | 2.43 | 2.448 | 2.255 | 2.26 | 3.255M |
Mar 21, 2024 | 2.47 | 2.59 | 2.39 | 2.41 | 2.909M |
Mar 20, 2024 | 2.43 | 2.52 | 2.37 | 2.49 | 1.643M |
Mar 19, 2024 | 2.48 | 2.575 | 2.41 | 2.44 | 2.895M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.00
Minimum
Oct 09 2023
9.09
Maximum
Feb 02 2021
3.040
Average
2.42
Median
Sep 12 2019
Price Benchmarks
Novavax Inc | 4.19 |
AIM ImmunoTech Inc | 0.4255 |
Perspective Therapeutics Inc | 1.70 |
Protalix BioTherapeutics Inc | 1.20 |
Armata Pharmaceuticals Inc | 2.53 |
Price Related Metrics
PS Ratio | 297.08 |
PEG Ratio | -0.065 |
Price to Book Value | 4.284 |
Earnings Yield | -49.38% |
Market Cap | 398.90M |
PEGY Ratio | -0.065 |